Skip to main content
LEVI logo

LEVI · Levi Strauss & Co

Track LEVI — free
$22.87 -0.23 (-1.00%) At close · Nov 6
Market Cap
$8.77B
Shares
383.47M
Volume · Nov 6 2.49M Avg daily vol (3M) 3.31M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$22.87 Open$22.67 Day$22.67–23.21 52W close$17.91–25.53 Avg vol 30d4.5M Short int9.0M · 2.3% of shares · 1.2d Short vol63% Last earningsOct 7, 2026 DataJan 2020–Nov 2026 Filing10-Q · Oct 7

Up next

Jan 7, 2027 Est · unconfirmed · in 9 wks

Latest documents

2026
Oct 7
Earnings call
Q3 2026 earnings call

Levi Strauss & Co. reported third-quarter organic revenue growth of 5%, but DTC grew 2% as U.S. and Europe traffic fell short; it expects fourth-quarter organic revenue growth of approximately 4% and named John Vandemore its next CFO.

Oct 7
Current report 8-K
Financial results

Levi Strauss & Co. reported third-quarter net revenues of $1.6 billion, up 4% reported and 5% organic, with 13.8% operating margin. It raised 2026 adjusted EPS guidance to $1.54 to $1.56 and plans a $100 million accelerated share repurchase.

Read from the first part of this long document
Oct 7
Quarterly report 10-Q FY2026 Q3, ended Aug 30
Quarterly report for FY2026 Q3

Levi Strauss & Co reported third-quarter net revenues up 4.3% to $1,609.7 million and net income from continuing operations of $168.6 million, boosted by a $78.6 million IEEPA tariff refund. It also completed the Dockers® sale on February 27, 2026.

Revenue $1.61B ▲ 4.3% Net income $168.6M ▼ 22.7% Diluted EPS $0.43 ▼ 21.8%
Read from the MD&A section
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$6.68B
Trailing 12 months
Net income (TTM)
$589.70M
Trailing 12 months
Revenue growth YoY
+4.3%
Year over year
Operating margin
11.3%
Trailing 12 months
P / E (TTM)
15.5
Trailing earnings · reciprocal yield 6.5%
FCF yield
7.3%
TTM · current market cap
Return on invested capital
22.0%
Trailing 12 months
Net cash
−$264.30M
Latest balance sheet
Dividend yield
2.6%
Trailing 12 months
Shares change YoY
-2.2%
Year over year · fewer shares
Price change (1Y)
+14.6%
Trailing year
Short interest
2.3%
Latest settlement · 1.2 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Moderate
Market backdrop VIX 25.6 · fear Equity put/call 0.59
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +5%
above
Price vs 50-day avg +11%
above
RSI (14) 63
neutral
MACD trend Positive
52-week position 65%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +22%
trailing
6-month return +9%
trailing
YTD return +10%
this year
Relative strength +10%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $21 › 200d $22 — 200d above 50d
Institutional flow Accumulating
146 of 324 funds reported for Sep 30 · net +2.4M sh shares · +22 new
Insider flow Distributing
Net -$83.4K over 90 days · 100% sells
Short interest Rising
2.35% of shares out · ▲ +4.1% MoM · 1.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
324 holders — near 3-yr high, broad support
Squeeze score 52
elevated · 0–100
Fundamentals
Excellent
Revenue growth +4%
Y/Y
Gross margin 62%
expanding
EPS growth +179%
Y/Y
Free cash flow $308.2M
Valuation P/E 15.4
below peers
Buyback $240.0M
remaining
Balance sheet $281.3M
net debt
Quant / Vol
risk profile
Moderate
Volatility 33%
annualized · 1-yr
Max drawdown −27%
past year
ATR 3.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 0 of last 2
Latest guidance · from the Earnings Call filed Oct 7, 2026
full year
Reported net revenues growth 7%
Organic net revenues 6%
Gross margin 63%
Adjusted SG&A as a percentage of revenue 51%
Adjusted EBIT margin 12.1%
Adjusted diluted earnings per share $1.54 – $1.56
fourth quarter
Gross margin 61.8%
Adjusted EBIT margin 11.4% – 11.6%
Previous outlook earlier release · from the 8-K filed Jul 8, 2026

Still-open targets the latest release did not restate under the same label.

Reported net revenues growth · year ending November 29, 2026 7% – 7.5%
Organic net revenues growth · year ending November 29, 2026 5.5% – 6%
Tax rate · year ending November 29, 2026 23%
Guided vs delivered · last 2 settled
Net revenues fiscal 2023
guided $6.3B – $6.4B
$5.84B Miss −8.0%
Net revenues growth fiscal 2022
guided $6.4B – $6.5B
$6.17B Miss −4.4%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+5% Bullish
Price vs 50-day avg
+11% Bullish
RSI (14)
63 Neutral
MACD trend
Positive Bullish
52-week position
65% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $21 › 200d $22 — 200d above 50d
Institutional flow Accumulating
146 of 324 funds reported for Sep 30 · net +2.4M sh shares · +22 new
Insider flow Distributing
Net -$83.4K over 90 days · 100% sells
Short interest Rising
2.35% of shares out · ▲ +4.1% MoM · 1.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
324 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $18 Now $23 · 65% Range high $26
vs 200-day avg +5% vs 50-day avg +11%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted SG&A margin non-GAAP 51.2% Nine Months Ended August 30, 2026 —
As reported and organic net revenues - Beyond Yoga® non-GAAP $121.9M Nine Months Ended August 30, 2026 —
Constant-currency Adjusted diluted earnings per share non-GAAP $1.19 Nine Months Ended August 30, 2026 —
Constant-currency Adjusted EBIT non-GAAP $607.7M Nine Months Ended August 30, 2026 —
Constant-currency Adjusted EBIT margin non-GAAP 12.4% Nine Months Ended August 30, 2026 —
Constant-currency Adjusted net income non-GAAP $465.4M Nine Months Ended August 30, 2026 —
Constant-currency Adjusted net income margin non-GAAP 9.5% Nine Months Ended August 30, 2026 —
e-commerce net revenues growth on a reported basis 10% the three months ended August 30, 2026 filing —
Operating margin 13.8% the three months ended August 30, 2026 filing —
Organic net revenues - Asia non-GAAP $924M Nine Months Ended August 30, 2026 —
Organic net revenues - DTC non-GAAP $2.43B Nine Months Ended August 30, 2026 —
Organic net revenues - Levi's® non-GAAP $4.6B Nine Months Ended August 30, 2026 —
Beyond Yoga operating income (loss) -$2.4M Three Months Ended May 31, 2026 filing —
Levi's Brands operating income (Americas) $164.1M Three Months Ended May 31, 2026 filing —
Levi's Brands operating income (Asia) $42.5M Three Months Ended May 31, 2026 filing —
Levi's Brands operating income (Europe) $88.8M Three Months Ended May 31, 2026 filing —
Organic net revenues growth non-GAAP 5.7% the second quarter of 2026 filing —
Total Levi's Brands operating income $295.4M Three Months Ended May 31, 2026 filing —
Weighted-average interest rate on average borrowings outstanding 4.61% Three Months Ended May 31, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Apparel Manufacturing — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
LEVI
Levi Strauss & Co
this stock
$8.77B +10.3% +4.1% 15.4 2.3%
HMRZF
H&M Hennes & Mauritz AB
$28.16B -12.2% — — 1.2%
RL
Ralph Lauren Corp
$22.35B +6.5% +14.6% 21.7 3.9%
MONRF
Moncler S.p.A.
$14.66B -20.7% — — 1.1%
VFC
V F Corp
$8.01B +12.6% -18.2% 31.8 9.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
336
% held
24.3%
Reported
146 of 324
Top holder
JPMORGAN CHASE & CO
Held Float
View
Held by Funds
Fund positions
207
View
Short & Settlement
Short Interest Rising
Shares short
9.0M
Days to cover
1.2d
Change
+351.4K sh
View
Short Volume
Short vol %
63%
As of
Nov 6, 2026
Short Total
View
Fails to Deliver
FTD shares
10.2K
Value
$207.4K
As of
Sep 2, 2026
View
Off-Exchange
Off-exchange %
42.8%
Week of
Sep 28, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$83.4K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$6.3B
Net income (FY)
$210.6M
EPS diluted
$1.45
View
Buybacks
Authorized
$750.0M
Remaining
$240.0M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Oct 7, 2026
This year
20

Levi Strauss & Co reported third-quarter net revenues up 4.3% to $1,609.7 million and net income from continuing operations of $168.6 million, boosted by a $78.6 million IEEPA tariff refund. It also completed the Dockers® sale on February 27, 2026.

View
Proposed Sales
Value
$83.4K
Shares
3.5K
Filed
Nov 4, 2026
View
Earnings & Events
Webcasts
Last webcast
Oct 7, 2026
View
Investor Relations
Latest news
Levi Strauss & Co. Reports Third-…
Published
Oct 7, 2026
View

Performance

5D 20D 120D MTD YTD
LEVI +1.6% +22.3% +9.1% +1.6% +10.3%
SPY -2.7% -5.6% -0.5% -2.7% +7.8%
vs SPY +4.3% +27.9% +9.6% +4.3% +2.4%

Capital returns

Latest dividend
$0.16 / share · ex Oct 21, 2026
Raised 14.3%
Paid (TTM)
$0.60 / share · 4 payouts
Dividend yield (TTM, derived)
2.62%
Full dividend history
Buyback program · as of Aug 30, 2026
Authorized
$750.00M
Spent (derived)
$510.00M
Remaining
$240.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 94845 CUSIP 52736R102 13F (30d) 163 filings 139 filers Visit website Investor relations